Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-787P is classified as a pseudogene variant of the U6 small nuclear RNA gene family[1]. U6 snRNA is a highly conserved non-coding RNA that acts as a catalytic component of the spliceosome, a complex responsible for excising introns from pre-mRNA in eukaryotes, but RNU6-787P itself does not produce a functional RNA product[1][5][7]. Pseudogenes like RNU6-787P are typically regarded as non-functional genomic remnants lacking protein-coding potential[1], though recent research supports possible indirect roles for transcribed pseudogenes in regulatory processes (e.g., acting as decoys for microRNAs or being a source of regulatory non-coding RNAs in rare cases)[4][6]. However, there is no direct evidence or published data indicating RNU6-787P is a therapeutic target, disease driver, or biomarker by itself[1][5]. It is not a receptor, enzyme, transporter, or transcription factor, but a non-coding pseudogene copy related to the U6 small nuclear RNA gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 787, pseudogene (RNU6-787P).